Dipeptidyl peptidase-4 inhibitors and cancer risk in patients with type 2 diabetes: a meta-analysis of randomized clinical trials. Ming Zhao. 1. , Jiayi Chen. 1.
Dipeptidyl peptidase-4 inhibitors and cancer risk in patients with type 2 diabetes: a meta-analysis of randomized clinical trials Ming Zhao1, Jiayi Chen1, Yanyan Yuan1, Zuquan Zou1, Xiaolong Lai1, Daud M Rahmani1, Fuyan Wang1, Yang Xi1, Qin Huang2*, Shizhong Bu1*
Table S1 Quality assessment of the randomized clinical trials included in the meta-analysis Selection bias Study
